BMJ  2008;336:1472-1474 (28 June), doi:10.1136/bmj.39590.732037.47

Analysis

What is missing from descriptions of treatment in trials and reviews?

¹ Centre for Evidence-Based Medicine, Department of Primary Health Care, University of Oxford, Oxford OX3 7LF, ² Department of Public Health, University of Oxford

Replicating non-pharmacological treatments in practice depends on how well they have been described in research studies

The first 150 words of the full text of this article appear below.

Have you ever read a trial or review and wondered exactly how to carry out treatments such as a "behavioural intervention," "salt reduction," or "exercise programme"? Although CONSORT and related initiatives have focused on the assessment of validity and presentation of results,^{1 2} less attention has been given to the adequacy of the description of the treatment used. For pharmacological treatments the description would need to include the dose, titration, route, timing, duration, and any monitoring used. For complex treatments the problems are even greater.

The uptake of positive findings from trials is often slow and sometimes negligible.³ Reasons for this slow uptake include clinicians not becoming aware of the results, perceiving the results as either invalid or not relevant to their patients, or simply not remembering to use the treatment.^{4 5} An additional barrier, which has received less attention, is clinicians’ ability to carry out the treatment on the basis of . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, and David Moher
BMJ 2009 339: b2700. [Abstract] [Full Text]

Critical thinking

Fiona Godlee
BMJ 2009 338: b1662. [Extract] [Full Text]

Developing and evaluating complex interventions: the new Medical Research Council guidance

Peter Craig, Paul Dieppe, Sally Macintyre, Susan Michie, Irwin Nazareth, and Mark Petticrew
BMJ 2008 337: a1655. [Full Text]

Graphical method for depicting randomised trials of complex interventions

Rafael Perera, Carl Heneghan, and Patricia Yudkin
BMJ 2007 334: 127-129. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Altman, D. G., Simera, I. (2009). Responsible reporting of health research studies: transparent, complete, accurate and timely. J Antimicrob Chemother 0: dkp410v1-dkp410 [Abstract] [Full text]  
• Simera, I., Altman, D. G (2009). Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. Evid. Based Med. 14: 132-134 [Full text]  
• Cates, C. (2009). Using education to improve control of asthma in children. CMAJ 181: 248-249 [Full text]  
• Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P.A., Clarke, M., Devereaux, P. J., Kleijnen, J., Moher, D. (2009). The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. ANN INTERN MED 151: W-65-W-94 [Abstract] [Full text]  
• Straus, S. E., Tetroe, J., Graham, I. (2009). Defining knowledge translation. CMAJ 181: 165-168 [Full text]  
• Clark, A. M., Savard, L. A., Thompson, D. R. (2009). What is the strength of evidence for heart failure disease-management programs?. J Am Coll Cardiol 54: 397-401 [Abstract] [Full text]  
• Liberati, A., Altman, D. G, Tetzlaff, J., Mulrow, C., Gotzsche, P. C, Ioannidis, J. P A, Clarke, M., Devereaux, P J, Kleijnen, J., Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700-b2700 [Abstract] [Full text]  
• Straus, S., Haynes, R. B. (2009). Managing evidence-based knowledge: the need for reliable, relevant and readable resources. CMAJ 180: 942-945 [Full text]  
• Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., Petticrew, M. (2008). Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337: a1655-a1655 [Full text]  

Rapid Responses:

Read all Rapid Responses

Descriptions also missing from pharmacological treatments in trials

Mario L de Lemos
bmj.com, 26 Apr 2009 [Full text]

Online poll

Find out more>>